Form 4 holding
Director
Caris Life Sciences, Inc.
- Security class
- Common Stock
- Shares / value
- 10,270,906
- Estimated value
- $272,179,009
- Report date
- 26 Feb 2026
- Price
- $26.50
- Ownership
- By CLS-PF-SPE, LLC
Peter M. Castleman - Director at Caris Life Sciences, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- CAI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Peter M. Castleman since 16 Aug 2025
Reported holdings for Peter M. Castleman in Caris Life Sciences, Inc.
Form 4 holding
Director
Caris Life Sciences, Inc.
- Security class
- Common Stock
- Shares / value
- 100,000
- Estimated value
- $2,650,000
- Report date
- 26 Feb 2026
- Price
- $26.50
- Ownership
- By Family Trust
Form 4 holding
Director
Caris Life Sciences, Inc.
- Security class
- Common Stock
- Shares / value
- 24,138
- Estimated value
- $484,208
- Report date
- 26 Feb 2026
- Price
- $20.06
- Ownership
- Direct
Form 4 holding
Director
Caris Life Sciences, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 20 Jun 2025
- Price
- Ownership
- By CLS-PF-SPE, LLC
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Caris Life Sciences, Inc.
- Security class
- Stock Option
- Shares / value
- 0
- Estimated value
- Report date
- 09 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Peter M. Castleman in Caris Life Sciences, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.